Abstract
HBV surface antigen (HBsAg) is the most important marker for the laboratory diagnosis of hepatitis B virus infection. Mutants can emerge in patients as result of selective pressure. Since almost all diagnostic assays for detection of HBsAg rely on antibodies against the major epitope a determinant, amino acid (aa) substitutions in this region could potentially lead to diagnostic failures. The new generation of HBsAg assays uses mixtures of monoclonal antibodies in order to recognize the known S gene mutants and ideally should be sensitive enough to detect the smallest amounts of HBsAg present in low-level carriers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.